Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to confirm that daily supplementation with a product containing a standardized combination of polyphenol-rich extracts has a protective effect against potential blue-light-induced damage to retinal cells.


Clinical Trial Description

Randomized, double-blind, parallel study conducted under medical supervision on a group of 54 volunteers exposed to blue-light for 6-8h a day. Patients receive one of the investigational products or placebo for 6 weeks. Study parameters: OCT (optical coherence tomography), Amsler test, Computerized Perimetry, Schirmer test. In addition, subjective symptoms will be assessed using the Visual Analog Scale (VAS) method and a Dry Eye-Related Quality-of-Life Questionnaire. The studied parameters will be measured before and after supplementation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06004570
Study type Interventional
Source AronPharma Sp. z o. o.
Contact
Status Completed
Phase N/A
Start date June 15, 2023
Completion date September 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT04190147 - Eye and Growth in Adolescents Born Moderate-to-late Preterm
Not yet recruiting NCT06408701 - Modeling Ocular Developmental Diseases From 3D Cultures of Optic Vesicle Organoids Derived From hiPSCs of Patients With Ocular Malformations
Completed NCT01740466 - Epidemiological Profile of Ophthalmological Care in the Public Service in Brazil N/A
Completed NCT04118738 - International Cohort Study of Children Born to Women Infected With Zika Virus During Pregnancy
Completed NCT04937725 - Reading Problems Associated With Central Nervous System (CNS) Pathologies.
Recruiting NCT02539381 - The Stroke Vision App: A Screening Tool for Visual Stroke N/A
Recruiting NCT05339880 - Relation Between Oculocardiac Reflex and Laryngospasm
Completed NCT02585063 - Independent Prescribing Optometrists in Acute Ophthalmic Services
Completed NCT04068818 - The Heidelberg Engineering ANTERION Imaging Agreement Study
Withdrawn NCT01458613 - Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)